Shivansh Nigam

Employment

• Sun Pharma Advanced Research Company Manager - In vitro Biology
  2024 - Present

Education

• Indian Institute of Technology Kanpur Ph.D.
  2015 - 2024
• Banaras Hindu University Faculty of Science M.Sc. Biotechnology
  2013 - 2015

Projects & Funding

Projects & funding information is unavailable.

Publications (8)

• DKC1 promotes colorectal cancer progression and therapy resistance by dysregulating sphingolipid biosynthesis
  Nature Communications 2026 DOI: 10.1038/s41467-026-72800-2
  +Save
• Transcriptional regulation of Dyskerinviacanonical WNT signaling modulates sphingolipid biosynthesis and drives colorectal cancer
  2023 DOI: 10.1101/2023.07.18.549480
  +Save
• Nuclear magnetic resonance spectroscopy reveals dysregulation of monounsaturated fatty acid metabolism upon SPINK1 attenuation in colorectal cancer
  NMR in Biomedicine 2022 DOI: 10.1002/nbm.4705
  +Save
• Abstract 6246: WNT signaling-mediated DKC1 expression drives stemness associated with colorectal cancer
  Cancer Research 2022 DOI: 10.1158/1538-7445.am2022-6246
  +Save
• Caspase-3 mediated programmed cell death by a gold-stabilised peptide carbene
  Bioorganic & Medicinal Chemistry Letters 2019 DOI: 10.1016/j.bmcl.2019.126672
  +Save
• Implications of the circular RNAs in localized prostate cancer
  Annals of Translational Medicine 2019 DOI: 10.21037/atm.2019.07.23
  +Save
• Epigenetic Silencing of miRNA-338-5p and miRNA-421 Drives SPINK1-Positive Prostate Cancer
  Clinical Cancer Research 2019 DOI: 10.1158/1078-0432.ccr-18-3230
  +Save
• Ag/AgO Nanoparticles Grown via Time Dependent Double Mechanism in a 2D Layered Ni-PCP and Their Antibacterial Efficacy
  Scientific Reports 2017 DOI: 10.1038/srep44852
  +Save